Lee David S, Herzog Jacques A, Walia Amit, Smetak Miriam R, Pavelchek Cole, Durakovic Nedim, Wick Cameron C, Ortmann Amanda J, Buchman Craig A, Shew Matthew A
Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri.
Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon.
Otol Neurotol. 2025 Aug 1;46(7):781-788. doi: 10.1097/MAO.0000000000004429. Epub 2025 Feb 14.
Evaluate variable qualification criteria for cochlear implant (CI) recipients and 12-month speech perception outcomes.
Retrospective cohort study.
HERMES national database and nonoverlapping single-institution CI database.
A total of 2,124 adult unilateral CI recipients categorized by qualifying status: AzBio in quiet (n = 1,239), +10 dB SNR (but not in quiet; n = 519), +5 dB SNR (but not in quiet or +10 dB SNR; n = 366); CNC ≤40% (n = 1,037), CNC 41% to 50% (n = 31), and CNC 51% to 60% (n = 20).
CI.
Pre- and 12-month postoperative speech perception performance. Clinically significant improvement was defined as ≥15% gain.
Quiet qualifiers experienced improvement in all listening conditions, whereas +10 dB SNR and +5 dB SNR qualifiers only improved in their qualifying condition and implanted ear CNC. When stratified by expanded Medicare criteria (binaural AzBio ≤60% correct), patients that qualified in quiet experienced improvements regardless of qualifying threshold or background noise. However, those that qualified in noise and AzBio ≤60% experienced mixed results in quiet and limited gain in background noise. When ≤60% criteria was applied to CNC of the worse ear, ≤40% qualifiers experienced large improvements in all tested conditions, but those who qualified by 41% to 50% or 51% to 60% only demonstrated modest improvements in AzBio sentence testing.
Quiet qualifiers improved in all testing conditions, while those qualifying in noise improved in their qualifying condition. Patients who qualified by expanded Medicare criteria (≤60%) showed improvement when qualifying with AzBio in quiet, but should be used with caution when qualifying patients in background noise or CNC due to more limited gains in performance.
评估人工耳蜗(CI)植入受者的可变资格标准及术后12个月的言语感知结果。
回顾性队列研究。
HERMES国家数据库和非重叠的单机构CI数据库。
总共2124名单侧CI成年植入者,根据资格状态分类:安静环境下AzBio测试合格(n = 1239),信噪比(SNR)为+10 dB(但非安静环境;n = 519),SNR为+5 dB(但非安静环境或SNR为+10 dB;n = 366);CNC得分≤40%(n = 1037),CNC得分41%至50%(n = 31),以及CNC得分51%至60%(n = 20)。
CI植入。
术前及术后12个月的言语感知表现。临床显著改善定义为增益≥15%。
安静环境下合格者在所有聆听条件下均有改善,而SNR为+10 dB和+5 dB的合格者仅在其合格条件及植入耳的CNC方面有所改善。当按照扩大的医疗保险标准(双耳AzBio正确率≤60%)进行分层时,安静环境下合格的患者无论合格阈值或背景噪声如何均有改善。然而,那些在噪声环境下合格且AzBio≤60%的患者在安静环境中的结果不一,在背景噪声中的增益有限。当将≤60%的标准应用于较差耳的CNC时,≤40%的合格者在所有测试条件下均有大幅改善,但那些以41%至50%或51%至60%合格的患者仅在AzBio句子测试中表现出适度改善。
安静环境下合格者在所有测试条件下均有改善,而在噪声环境下合格者在其合格条件下有改善。通过扩大的医疗保险标准(≤60%)合格的患者在安静环境中进行AzBio测试合格时表现出改善,但在背景噪声或CNC条件下对患者进行资格评估时应谨慎使用,因为其性能增益较为有限。